title: Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.
abstract: Squalene-based oil-in-water emulsions have been used for years in some seasonal and pandemic influenza vaccines. However, concerns have been expressed regarding squalene source and potential biological activities. Little information is available regarding the immunomodulatory activity of squalene in comparison with other metabolizable oils in the context of oil-in-water emulsions formulated with vaccines. The present work describes the manufacture and physical characterization of emulsions composed of different classes of oils, including squalene, long chain triglycerides, a medium chain triglyceride, and a perfluorocarbon, all emulsified with egg phosphatidylcholine. Some differences were apparent among the non-squalene oils in terms of emulsion stability, including higher size polydispersity in the perfluorocarbon emulsion, more rapid visual instability at 60°C for the long-chain triglyceride and perfluorocarbon emulsions, and an increased creaming rate in the medium-chain triglyceride emulsion at 60°C as detected by laser scattering optical profiling. The biological activity of each of these emulsions was compared when formulated with either a recombinant malaria antigen or a split-virus inactivated influenza vaccine. Overall, vaccines containing the squalene emulsion elicited higher antibody titers and more abundant long-lived plasma cells than vaccines containing emulsions based on other oils. Since squalene-based emulsions show higher adjuvant potency compared to the other oils tested, non-squalene oils may be more suitable as carriers of amphiphilic or hydrophobic immunostimulatory molecules (such as TLR agonists) rather than as stand-alone adjuvants.
authors: Infectious Disease Research Institute, 1124 Columbia St., Ste 400, Seattle, WA 98104, United States. cfox@idri.org
authors: Christopher B
authors: CB
authors: Fox
authors: Susan L
authors: SL
authors: Baldwin
authors: Malcolm S
authors: MS
authors: Duthie
authors: Steven G
authors: SG
authors: Reed
authors: Thomas S
authors: TS
authors: Vedvick
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000737:chemistry; D000914:Antibodies, Viral / Q000096:biosynthesis; D004531:Eggs; D004655:Emulsions; D005466:Fluorocarbons / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors; D009821:Oils / Q000009:adverse effects; D010713:Phosphatidylcholines / Q000276:immunology; D013185:Squalene / Q000009:adverse effects / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D004655:Emulsions; D005466:Fluorocarbons; D007155:Immunologic Factors; D009821:Oils; D010713:Phosphatidylcholines; D014765:Viral Vaccines; D013185:Squalene